Jeroen is a Stanford-trained life science investment and BD professional with a 12+ years track record in Venture Capital investing in high-impact startups and executing partnerships in an academic, industry, non-profit and VC setting. As an operator he has worked at director, CBO, and CEO level, with a track record of company formation and negotiating pharma- and biotech-partnerships.

Jeroen joined General Inception in 2022 where he leads academic innovation sourcing and VC partnerships in Europe. General Inception is a Palo Alto (USA) based venture builder, and through it’s European team, Igniter Europe, Jeroen has helped spin-out and co-found Tavira Therapeutics in Leuven, sCellgen in Utrecht, and led investments in Pharmacelara in Barcelona, o.a.

Jeroen has worked in Silicon Valley for almost 8 years where he, prior to returning to the Netherlands, led BD and partnerships at the Parker Institute for Cancer Immunotherapy in San Francisco. Here he managed an IP portfolio of 110 inventions across 6 member TTOs: UCSF, UCLA, Stanford, MD Anderson CC, MSKCC, and Upenn; of which 19 had been out licensed or optioned, 5 resulted in company formation. At PICI, Jeroen was involved with early investments in Arsenal Biosciences, ImaginAb, Xyphos Biosciences, Lyell Immunopharma, 3T Biosciences, o.a., executed clinical partnerships with BMS and Amgen, and co-funding partnerships with non-profits Cancer Research Institute, Breast Cancer Research Fund, and CureSearch.

He gets his energy from connecting with innovators and now uses his operational and investment experience to help amazing founders build high-impact companies.